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Abstract
This study

investigated the role of estrogen receptor activation on total and

proliferating satellite cells following running exercise in rats, by using an estrogen
receptor-alpha (ER-a) specific agonist, 4,4,4 (4-Propyl-[1H]-pyrazole-1,3,5-triyl)
trisphenol (PPT). PPT is the first ER-a specific agonist (Stauffer et al 2000)
which binds the ER-a subtype with a 410-greater affinity than ER-(3 (Stauffer et
al 2000). Previous studies have demonstrated that estrogen can augment
muscle satellite cell numbers following exercise (Enns and Tiidus, 2008) and
that

this augmentation may be due to mechanisms activated via estrogen

receptors that can influence total, proliferating, and differentiating satellite cell
numbers (Enns et al 2008). Ovariectomised female rats (n = 64) were divided
into four groups: sham, estrogen (0.25 mg estrogen), agonist (PPT), and
estrogen plus PPT. Each group was further divided into exercisers and controls
(non-exercisers).

PPT administration commenced 2 days after

estrogen

implantation and continued for 6 days. After 7 days of estrogen exposure,
exercisers ran intermittently for 90 minutes (17m/min, -13.5 degree grade).
Soleus and white vastus muscles were removed 72 hours post-exercise and
immunohistochemically stained for total (pax7) and activated (MyoD) satellite
cells. Severity of muscle damage was assessed indirectly by measuring betaglucuronidase activity. The results revealed that there were significant increases
(p < 0.05) in fibers staining positive for total (pax7) and activated (MyoD) satellite
cells when compared to shams in both the soleus and white vastus muscles.
However, there was no significant difference (p > 0.05) observed between the
treatment conditions supplemented with estrogen, PPT, and estrogen plus PPT.
Augmented increases observed in muscle satellite cells post-exercise in the PPT
supplemented group suggests that their activation is an estrogen receptormediated process. Due to no significant difference (p > 0.05) observed between
PPT- and estrogen-mediated activation of ER-a receptors, ER-a is implicated as
the receptor responsible for most, if not all, of the activation of satellite cell
activity when induced by estrogen.
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Calcium
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Estradiol-17(3
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List of Definitions
Agonist: A chemical that binds and activates a receptor and could be
considered as a full or partial agonist.
• A full agonist is highly efficient producing a full response
while occupying a relatively low proportion of receptors.
• A partial agonist has lower efficiency than a full agonist. It
produces sub-maximal activation even when occupying the
total receptor population, therefore cannot produce the
maximal response.
Antagonist: A chemical that attenuates the effect of an agonist, and can be
either competitive or non-competitive.
• A competitive antagonist binds to the same site as the
agonist but does not activate it, thus blocks the agonist's
action.
• A non-competitive antagonist binds to an allosteric (nonagonist) site on the receptor to prevent activation of the
receptor.
Antioxidant: An antioxidant is a molecule capable of neutralising the oxidation
of molecules. Oxidation is a chemical reaction that transfers
electrons from a substance to an oxidizing agent.
Apoptosis: Apoptosis is a form of programmed ceN death in multicellular
organisms.
Beta-Glucuronidase:

Glucuronidases are enzymes that cleave molecules to
produce glucoronic acid by cutting glvcosidic bonds.
Therefore they are classified as glycoside hydrolases
that
cleave
glucuronides.
In
eukarvotes.
glucuronidase is located in lysosomes and are
important in recycling cellular components.

Chemotaxis: Chemotaxis is the organisation of movements according to certain
chemicals/stimuli in the environment. Neutrophils, for example,
undergo chemotaxis that allows them to migrate toward sites of
infection or inflammation.
Concentric Contraction: The forces produced by the muscle are sufficient to
overcome the resistance, and causes the muscle to
shorten as it contracts.
Creatine Kinase:

Creatine
kinase
(CK), also
known as
creatine
phosphokinase (CPK) or phosphocreatine kinase, is an

VII

enzyme that catalyses the conversion of creatine to
phosphocreatine, utilising adenosine triphosphate (ATP) and
generating adenosine diphosphate (ADP). In tissues such as
skeletal muscle, that utilises ATP rapidly, phosphocreatine
serves as an energy reserve for the rapid conversion to ATP.
Cytokines: Similar to hormones and neurotransmitters, cytokines are signalling
proteins and glycoproteins
used
primarily for cellular
communication.
Degranulation:

Neutrophils release an assortment of proteins in three types
of granules by a process called degranulation.

Eccentric Contraction:

Forces generated by the muscle are insufficient to
overcome the resistance resulting in muscle fibres
lengthening as they contract.
An eccentric
contraction can also be considered as a means of
decelerating a body part.

Fast Twitch Fibres: Fast-twitch (type II or white) fibres have fewer mitochondria,
are capable of more powerful (but shorter) contractions,
metabolize ATP more quickly, have a lower capillary to
volume ratio, and are more likely to accumulate lactic acid.
Type II fibres are distinguished by their primary sub-types,
lla, llx, and Mb. Weiqhtlifters and sprinters are examples of
athletes who tend to have more type II fibres.
Fibroblasts: Fibroblasts synthesize and maintain the extracellular matrix.
Fibroblasts provide a structural framework for many tissues, and
play a critical role in wound healing.
Free Radical Species:

Histology:

Free radicals are atoms, molecules or ions with
unpaired electrons on an open shell configuration.
These unpaired electrons are typically highly reactive,
making radicals likely to participate in chemical
reactions.

Histology is the study of examining the microscopic anatomy of
cells and tissues by viewing a thin slice under a light microscope.

Immunohistochemistry: Immunohistochemistry (IHC) is a process of localizing
cell proteins in tissue sections relying on antibodies
binding to antigens.
Inflammation:

Inflammation is the response of vascular tissues to harmful
stimuli such as pathogens, damaged cells, or irritants. It is a

VIII

process that attempts to remove the injurious stimuli as well
as initiate the healing process for the tissue.
Isometric Contraction:

The muscle maintains the same length regardless of
building tension.

Isotonic Contraction:

Occurs when tension in the muscle remains constant
despite a change in muscle length. This occurs when
a muscle's maximal force of contraction exceeds the
total load on the muscle.

Leukocytes:

White blood cells, or leukocytes, are cells of the immune
system that defends the body against infectious diseases
and foreign materials.

Macrophages:

Macrophages are cells that originate from white blood cells
called monocytes. Monocytes and macrophages are
phagocytes, acting in both non-specific as well as specific
defense systems of vertebrate animals. Their role is to
engulf and digest cellular debris and to stimulate
lymphocytes and other immune cells to respond to the
pathogen.

Monocytes: Monocytes are leukocytes, and have two main functions in the
immune system: (1) replenish resident macrophages and dendritic
cells under normal states, and (2) in response to inflammation
signals, monocytes can move quickly (approximately 8-12 hours) to
sites of infection and divide/differentiate into macrophages and
dendritic cells to elicit an immune response.
Myoblasts: Myoblasts are a type of stem cell that exist in muscles. The fusing
of myoblasts gives rise to new skeletal muscle fibres. Myoblasts
that do not form muscle fibres differentiate into satellite cells.
MyoD:

MyoD is a protein with a pivotal role in regulating muscle
differentiation and is one of the earliest markers identifying
myogenic commitment. MyoD is expressed in activated satellite
cells, but not in quiescent satellite cells.

NADPH Oxidase:

NADPH oxidase (nicotinamide adenine dinucleotide
phosphate-oxidase) is a membrane-bound enzyme complex
found in the plasma membrane and membranes of
phagosomes. This complex is normally latent but is activated
to assemble in the membranes during a respiratory burst. It
aids in the generation of superoxide, a highly-reactive freeradical, by transferring electrons from NADPH inside the cell

IX

across the membrane and donating them to molecular
oxygen.
Necrosis:

Necrosis is the unnatural death of cells and living tissue. It
commences with cell swelling, chromatin digestion, and finally,
disruption of the plasma membrane and organelle membranes.

Neutrophils: Neutrophils are normally found in the blood stream. During the
acute phases of inflammation, neutrophils migrate toward the site of
inflammation, firstly initially through the blood vessels, then through
interstitial tissue, following chemical signals.
Pax-7:

P21(CDKN1A)-activated kinase 7 (Pax-7) is a human gene. The
proteins encoded by this gene have been identified in the regulation
of cytoskeletal dynamics, proliferation, and cell survival signalling.
Pax-7 is expressed in all quiescent, activated and proliferating
satellite cells.

Phagocytosis:

The capability of ingesting microorganisms or particles.

Respiratory burst: Neutrophils are capable of ingesting microorganisms or
particles. With each phagocytic event, reactive oxygen
species and hydrolytic enzymes are secreted. The utilisation
of oxygen during the generation of reactive oxygen species
has been defined as the respiratory burst. The respiratory
burst requires the activation of the enzyme NADPH oxidase,
which produces superoxide, a reactive oxygen species.
Slow Twitch Fibres: Slow-twitch (type I or red) fibres have greater amounts of
mitochondria, an increased capillary to volume ratio, store
oxygen in myoglobin, rely on aerobic metabolism, produce
ATP more slowly, and are relied upon for endurance events.
Superoxide: Superoxide is the anion 02~. It is produced as the product of the
one-electron reduction of dioxvgen. With one unpaired electron, the
superoxide ion is a free radical.

x

Chapter One
Introduction
Skeletal muscle is one of the three major muscle types found within
humans, the others being cardiac and smooth muscle. Skeletal muscle, which is
held together by connective tissue, is comprised of muscle fibers that enable
muscles to contract. Beside the ability of skeletal muscle to contract and
generate force for locomotion, breathing and postural support, other functions
include: fuel storage, temperature regulation, and acting as a force absorber.
However, the proper functioning of skeletal muscle can be disrupted as a result
of injury, disease condition, or overtraining (Hawke & Garry 2001, Wazniak ef al
2005).

1.1 Skeletal Muscle Damage
Injuries to skeletal muscle fibers can occur in a number of ways such as
sharp or blunt trauma, extreme temperatures, myotoxic agents, ischemia, muscle
disease (such as dystrophy), inflammation and contractions of the muscles
(Faulkner et al 1993). All of the aforementioned mechanisms by which skeletal
muscles can be damaged results in some or all of the fibers undergoing necrosis
(Faulkner et al 1993). Regardless of the contributing factor(s) that result in
skeletal muscle fiber damage; the fiber damage and repair process follow a
common pathway (Faulkner et al 1993). Injury induced as a result of shortening
(concentric), Isometric, or lengthening (eccentric) contractions can occur
however, there is a greater likelihood of injury resulting from eccentric
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contractions. Data collected by McCully & Faulkner (1985) revealed that in
comparison to concentric and isometric contractions, eccentric contractions
elicited significantly greater injury to muscle fibers as illustrated by an increased
number of fibers demonstrating histological signs of injury (McCully & Faulkner
1985). When taken into account that eccentric exercise is not as metabolically
strenuous, as well as producing less lactic acid than that of concentric
contractions (Clarkson & Sayers 1999); mechanical stresses imposed upon the
structural elements of the muscle fibers from eccentric contractions provide an
explanation

as to the

damage

that

occurs.

Faulkner

and

colleagues

demonstrated, using the extensor digitorum longus (EDL) muscle in mice, that
there is a greater development of average forces during lengthening compared to
shortening or isometric contractions (Faulkner et al 1993). They also state that:
a) the force developed during eccentric contractions was approximately twofold
greater in comparison to the force generated by maximum isometric contractions,
and b) the number of strongly bound cross-bridges was approximately 10%
greater than that of isometric contractions (Faulkner et al 1993). Therefore,
increases in force generated during an eccentric contraction results in an
increased strain on the individual cross-bridges. One reason for the greater
damage incurred by eccentric contractions lies in the number of motor units
recruited. Eccentric contractions recruit fewer motor units than concentric
contractions and therefore provide a smaller cross-sectional area of muscle
activated to handle the load (Clarkson & Sayer 1999).
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With the use of electron micrographs, changes are observed in
sarcomere lengths caused by lengthening contractions. During eccentric
contractions, some sarcomeres tend to maintain their lengths while weaker
sarcomeres are stretched to the point beyond overlap. If this process occurs on
the descending limb of the length-tension curve, sarcomeres will progressively
get weaker until there is no longer any overlap between myofilaments, and it is
the rising passive tension in elastic elements that balances the tension in the
remaining unstretched sarcomeres (Proske & Allen 2005). It is the inability of
overstretched sarcomeres to reintegrate upon relaxation of the muscle that
causes them to be disrupted and lie scattered randomly along the length of the
sarcomere. As the number of disrupted sarcomeres increases, damage may
spread longitudinally to adjacent sarcomeres and transversely to adjacent
myofibrils (Proske & Allen 2005). A point will be reached when overstretched
sarcomeres will lead to membrane damage, which includes the membranes of
the sarcoplasmic reticulum, transverse tubules, or the sarcolemma which in turn
is accompanied by an influx of calcium into the sarcoplasm.
Excess calcium entering the sarcoplasm due to muscle membrane
damage, can affect calcium homeostasis but also activate calpain (Belcastro et
al 1998). Activation of calpain is believed to play a role in muscle damage by
selectively degrading various contractile, metabolic and/or structural elements
(Belcastro et al 1998). Calpain is a non-lysosomal protease located in the I and
Z regions of muscle and cleaves a number of substrates which include desmin,
a-actinin, vimentin, spectrin, integrin, and cadherin (Belcastro et al 1998).
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Calpain is activated by elevated cystolic calcium concentrations which in turn
affects/cleaves specific muscle proteins and gives rise to the production of
neutrophil chemoattractive products (Tiidus et al 2001; Tiidus 2003). Calpain is
activated during exercise, and it is believed that calpain, or at least the peptide
fragments it creates, are associated with some of the neutrophil chemotaxis
observed immediately post-exercise (Belcastro etal 1998).
Electron micrographs allow for focal damage of the ultrastructure to be
observed (displacement of the thick filament to one Z-line, crumpling of the
interface between thick and thin filaments, and disorganization of the Z-lines) of
single sarcomeres within specific fibers (Faulkner et al 1993). Histological
abnormalities such as disarray of banding patterns in less than 5% of muscle
fibers (Armstrong et al 1983) have been observed as a widening of the l-band in
certain regions of myofibers in longitudinal sections and no clear differentiation in
some regions between adjacent muscle cells (Armstrong et al 1983) which were
not observed in the controls. The explanation provided of the aforementioned
observation was a possible disruption of the sarcolemma (Armstrong et al
1983).
Researchers have also observed structural abnormalities such as
disruption in the striation pattern of slow twitch fibers of the extensor muscles in
rats following downhill running, Z-line disorganization in human soleus muscle
two days post-exercise (Maclntyre et al 1995), extensive sarcomeric disruptions
that occurred in the quadriceps muscle of humans immediately post-exercise,
streaming and smearing of the z-lines, focal loss of Z-lines, and extension of the
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Z-line into the A-band (Lieber et al 1991). Armstrong and colleagues (Maclntyre
et al 1995) observed that Z-disk smearing was: multifocal within the same fiber,
did not extend full the length of the fiber, infrequently spanned more than three
sarcomeres, and in these areas, thick filaments overlapped each other and/or the
l-bands (Lieber et al 1991).
Muscle proteins that are typically affected by eccentric contractions and
contribute to the changes observed at the Z-lines are dystrophyn, desmin,
fibronectin (diagram 1 depicts the sequence of events leading to Z-line changes).
Dystrophyn is a submembrane protein that interacts with actin and
glycoproteins in the sarcolemma which, as a result, functions to stabilise the
sarcolemma during contractions. Changes that occur in the dystrophynglycoprotein complex caused by eccentric contractions could affect other
membrane proteins such as ion channels which in turn could alter calcium
homeostasis (Komulainen et al 1999). Dystrophyn disruption can be used as a
direct marker of myofiber membrane disruption which was found to increase
during the early phase of recovery and dissipating towards the end of the first
week of recovery (McClung et al 2006).
Desmin is a cytoskeletal protein specific to muscle which helps in the
maintenance of muscle fibre integrity, synchronization of contractions, and is
susceptible to proteolysis, particularly in the presence of calcium (Komulainen et
al 1999).
Fibronectin, an extracellularly located matrix-organising glycoprotein,
helps with the repair process by stimulating cell attachment and migration, as
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well as forming components of the initial connective tissue matrix (Komulainen
et al 1999).
Changes in the aforementioned proteins resulting from exercise become
useful for estimating the early phases of myofiber damage prior to observable
histopathological changes (Komulainen et al 1999).
Lysosomalacis hydrolase, (3-glucuronidase, activity provides a useful, but
indirect indicator/marker of the histopathological state and extent of exerciseinduced damage of skeletal muscle (Enns & Tildus 2008; Komulainen et al
1999). (3-glucuronidase is a lysosomal enzyme comprised of four identical
subunits and is involved in the stepwise degradation of glucuronic acidcontaining glycosaminoglycans (Shipley & et al 1993). Lysosomal changes are
associated with the muscle repair process and increases in total lysosomal acid
hydrolases originate in invading inflammatory phagocytes as well as surviving
muscle fibers (Salminen & Kihlstrom 1985). Increases in the levels of several
lysosomal acid hydrolases were observed when the total activities of acid
hydrolases was used as a quantitative measure of exercise-induced muscle
injury revealing a high correlation between lysosmal enzyme activities and the
histopathologic state of skeletal muscle (Salminen & Kihlstrom 1985).
Increased ^-glucuronidase activity was observed in both males and females 48
and 96 hours post-exercise, however, the increase was much smaller in females
(Komulainen et al 1999). Increased 3-glucuronidase activity tested 48 hours
post-exercise

was

70 and 300% for females

and

males

respectively

(Komulainen et al 1999). Komulainen and colleagues also observed female
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soleus

muscles

that

were

undamaged

((3-glucuronidase

activity

and

histopathological changes were not observed) during the seven day period postexercise after following a similar protocol proven to cause damage to the
soleus muscle in male rats (Komulainen et al 1999).
Measurement of creatine kinase (CK) in the circulation, similar to pglucuronidase activity, is useful for providing indirect evidence of post-exercise
muscle damage. CK is a metabolic enzyme primarily located in the intracellular
space of muscle. Due to its solubility characteristics, CK has the ability to cross
the sarcolemma if damaged and enter the circulation (Bar & Amelink 1997). CK
may not be an ideal marker to assess structural muscle damage however,
changes in CK circulation can be used as a marker of sarcolemma disruptions
from exercise or muscular activity (Tiidus 2008).

1.2 Skeletal Muscle Inflammation
Muscle

damage

induced

by

eccentric

contractions

elicits

an

inflammatory response. Inflammation causes the movement of fluid, plasma
proteins, and leukocytes into the tissue when responding to injury, which in turn
promotes the clearance of damaged tissue and prepares the tissue for repair.
There are many aspects that comprise the inflammatory response, however, for
the purposes of this paper, the roles of neutrophils and macrophages in the
removal of damaged tissue as well as the repair process of muscle will be
discussed.
One of the first steps of the inflammatory response is the accumulation of
neutrophils in the area of muscle damage. Neutrophil infiltration into the area of
7

exercise-induced muscle damage begins prior to the cessation of exercise,
continuing to increase rapidly over the following 12-24 hours and lasting for as
long as 5 days post-exercise (Tiidus et al 2001). Because the invasion of
macrophages into the damaged area typically occurs 12-24 hours post-exercise
(Tidball et al 1999; Tiidus et al 2001), neutrophils would encompass the
majority of leukocytes observed 1 hour post-exercise in rat skeletal muscle
(Tiidus et al 2001).
Neutrophils contain and destroy damaged tissue or foreign matter
primarily through phagocytosis; however, they can undergo a respiratory burst
and degranulation (Toumi et al 2006). Neutrophils have the capability of
generating hypochlorous acid via an MPO-mediated reaction and superoxide
(O2-) via NADPH oxidase that could possibly contribute to further muscle
damage during injury (Toumi et al 2006). Data obtained by Raj and colleagues
indicated immediate post-exercise calpain activation and myeloperoxidase
(MPO) activity in rodent skeletal muscle (Raj et al 1998, Tiidus et al 2001). They
observed a correlation in calpain-like protease and MPO activities (r=0.83) and
that their underlying processes were connected (Raj et al 1998). These reactions
ultimately assist with breakdown and clearance of damaged tissue to help
promote tissue repair (Toumi et al 2006).
Macrophages are similar to neutrophils in that they have the ability to
produce oxygen free radicals and cytotoxic enzymes which lead to tissue
degradation (Maclntyre et al 1995). Macrophage induced membrane lysis in
vitro occurs via nitric oxide (NO)-dependant and

superoxide-independent
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processes

(Tidball

&

Wehling-Henricks

2007).

NO-mediated

lysis

of

membranes is exacerbated in the presence of neutrophils, suggesting that
interactions between myeloid cell populations contribute to their cytotoxicity while
interactions of myeloid cells and muscle seem to be under the control of musclederived factors (in vitro), which in turn, promote NO release from macrophages
(Tidball & Wehling-Henricks 2007). However, Tidball and Wehling-Henricks
were unable to find supporting evidence of macrophage-mediated damage to
muscle cell membranes during loading after a period of unloading (Tidball &
Wehling-Henricks 2007). Tidball and Berchenko demonstrated that the majority
of the influx of extracellular materials into the muscle via damage to the cell
membrane occurred within the first 2-24 hours post-injury regardless of muscle
loading during this period (Tidball et al 1999). Observations of ED1 +
macrophages in the soleus muscle after reloading did not differ from controls
indicating that membrane damage during 2-24 hours was independent of
mechanical loading or ED1+ macrophage invasion during that period (Tidball et
al 1999).
Macrophages are the most abundant inflammatory leukocytes 12 hours
post-exercise and are the primary removers of cellular debris. ED1 + and ED2+
are subpopulations of macrophages that have been observed in animal tissue
(Clarkson & Sayer 1999). ED1+ macrophages appear 12 hours post-exercise
contributing to the removal of necrotic tissue, phagocytosing apoptic neutrophils
(McClung et al 2006), and cytokine production, while ED2+ macrophages
appear 24-48 hours post-exercise to help regulate the repair process as they
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tend to appear after muscle necrosis is complete and muscle repair begins
(Clarkson & Sayer 1999; Kendall & Eston 2002; Tiidus 2003). ED2+
macrophages contribute to the repair process by stimulating satellite cell
activation and differentiation, but the repair of damaged muscle will not occur
unless these macrophages are present (Clarkson & Sayer 1999; Tiidus 2003).
It is suggested that macrophages are involved with the cell cycle regulation of
myoblasts by the substances they secrete. Using MyoD as a marker of skeletal
myoblasts, a doubling of the number of myonuclei was observed prior to
myoblast fusion (Massimo et al 1997). The overall increase in nuclei observed in
comparison to controls was attributed to myoblast proliferation and as a result,
this evidence leads to supporting the hypothesis that macrophages possess a
muscle specific proliferative effect (Massimo et al 1997).
In vitro findings indicate that macrophages can increase proliferation of
myoblasts in culture and increase the proportion of myoblasts that express MyoD
suggesting that macrophage-derived factors play a role in muscle growth and
differentiation (Tidball & Wehling-Henricks 2007). Observations made after a
single bout of downhill running, rats had elevated neutrophil and ED1 +
macrophages while there were non-significant changes in ED2+ macrophages
and MyoD+ cells (Tsivitse et al 2003). They felt that the elevations in neutrophil
and ED1+ macrophages occur independently of changes in MyoD+ cells
(Tsivitse et al 2003). ED2+ macrophages were observed not to be elevated 72
hours post-exercise which seems to contradict previously reported elevations in
ED2+

macrophages

48

hours

post-exercise

encompassing

lengthening
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contractions (Tsivitse et al 2003). The explanation provided by the authors was
that their downhill-running protocol may not have been sufficient to elicit enough
injury in the soleus muscle as to observe increases in ED2 macrophages
(Tsivitse et al 2003).
Macrophages, along with immune and non-immune cells, are important for
producing/releasing cytokines, that aid in the inflammatory response during
skeletal muscle repair (St. Pierre Schneider et al 1999) such as interleukin-1
(IL-1(3), IL-2, IL-6 and tumour necrosis factor-a (TNF-a) (McClung et al 2006).
Interleukin-1 (3 is responsible for stimulating proteolytic enzyme synthesis,
leucocyte adhesion and extravasion, activation of macrophages, and expression
of other interleukins such as IL-2, IL-3, IL-6 and tumour necrosis factor-a (TNF-a)
(McClung et al 2006). IL-6, a pro-inflammatory cytokine, provides an early
stimulus for satellite cell activation and affects protein synthesis during skeletal
muscle recovery (McClung et al 2006). Cytokines play an important role in
inducing the synthesis of prostaglandins and are both involved in the mediation
of the inflammatory process and inducing satellite cell activation (McClung et al
2006). For example, Cyclo-oxenase-2 (COX-2) is an enzyme crucial for
successful and timely skeletal muscle regeneration (McClung et al 2006).

1.3 Skeletal Muscle Repair
During periods of growth and repair from injury, or in disease conditions,
satellite cells have the ability to increase muscle mass and repair muscle after
damage which makes them essential for the normal adaptive functions of skeletal
muscle (Wozniak et al 2005). Satellite cells are muscle precursor cells that lie
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between the external lamina and sarcolemma of skeletal muscle fibers. It is the
commencement

of damaged

tissue

removal that

causes

muscle

fiber

regeneration to begin under extensive control by the state of the external lamina
and sarcolemma, growth factors, and mechanical events affecting fibers
(Wozniak et al 2005). Muscle regeneration can be considered as undergoing
four stages: 1) satellite-cell activation, 2) myoblast or precursor proliferation, 3)
precursor differentiation, 4) return to quiescence (Wozniak et al 2005).
Satellite cells normally are in a state of quiescence, but as a result of
myofiber injury and or hypertrophic signals they enter the cell-cycle where
proliferation and differentiation occur to provide the necessary precursors
involved in the skeletal muscle growth and repair process (Enns & Tiidus 2008).
Satellite cell activation and proliferation are under the control of various
factors that arise due to tissue damage and inflammation, which include nitric
oxide (NO) and insulin-like growth factor 1 (IGF-1) (Machida & Booth 2004;
Anderson 2000). These factors are known to activate satellite cells post-injury
and subsequently maybe affected by estrogen levels (Stupka & Tiidus 2001).
Insulin-like growth factors I and II (IGF-1 and IGF-2 respectively) for
example, are secreted from skeletal muscle and contribute to the regulation of
satellite cell proliferation and differentiation (Hawke & Garry 2001). Overload of
skeletal muscle or eccentric exercise elicits an increase in IGF-1 levels,
increased DNA content (indicating an increase in satellite cell proliferation), and
hypertrophy of skeletal muscle (Hawke & Garry 2001). IGF-1 uses multiple
signalling pathways such as calcineurin/NFAT, mitogen-activated protein kinase
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(MAPK), and phophatidylinositol-3-OH kinase (PI3K) pathways in the regulation
of satellite cells (Hawke & Garry 2001). It has been proposed that IGF-1
stimulation of satellite cell differentiation seems to be controlled by way of the
PI3K pathway (Hawke & Garry 2001).
Besides the roles that IGF-1 and IGF-2 have in regard to satellite cell
stimulation and activation, there are other factors included in this process.
Hepatocyte growth factor (HGF) is a cytokine that has been localized, along with
its receptor c-Met, in satellite cells and adjacent myofibers but not in adjacent
fibroblasts (Hawke & Garry 2001). HGF expression has been observed to be
proportional to the extent of muscle injury, but has been implicated in a number
of roles for satellite cell regulation such as a potent chemotactic factor, activator
of satellite cells, and inhibitor of myoblast differentiation (Hawke & Garry 2001).
C-met receptor activity is essential for satellite cell activation and is expressed by
both quiescent and activated satellite cell populations. HGF binds to the satellite
cell c-met receptor which initiates satellite cell activation (Wozniak & Anderson
2007).
lnterleukin-6 (IL-6), a cytokine produced by a number of cells which
include myoblasts and macrophages, has its importance in the degradation of
necrotic tissue, synchronization of the satellite cell cycle, and inducing apoptosis
of macrophages after muscle injury, however, IL-6 is not involved with increases
in satellite cell proliferation (Hawke & Garry 2001).
It is worth mentioning that the migratory capabilities of satellite cells are
dependant on the structural integrity of the basal lamina. A rupture or disruption
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of the basal lamina resulting from myotrauma allows satellite cells to infiltrate
adjoining myofibers using tissue bridges, whereas when the basal lamina
remains intact, satellite cells migrate from the proximal portion of the myofiber to
the area of injury (Hawke & Garry 2001).
What has been outlined to this point are some of the key aspects involved
with the muscle damage and repair process and the remainder of this paper will
be focusing on the roles of estrogen, and estrogen receptors. As a result,
components of the inflammatory response and satellite cells will be readdressed
and further elaborated upon.

1.4 Influence of Estrogen
Estrogens are 18-carbon steroid molecules secreted primarily by the
ovaries as well as, but to a lesser extent, from the testes, and the adrenals in
both males and females (Kendall & Eston 2002). Estrogen is the term used in
reference to three structurally similar steroid hormones, estradiol-170 (E2),
esterone (E1), and estriol (E3) but E2 is the primary form of estrogen found in
humans, as well as having the greatest estrogenic properties and as a result, E2
is the most commonly studied (Kendall & Eston 2002).
Estrogen is believed to act as an antioxidant or membrane stabilizer
(Komulainen et al 1999; Warren et al 2001; Tidball & Wehling-Henricks
2007) and it is speculated based upon observations made with exercise-induced
myofiber damage that estrogen may act to improve the structural integrity of the
plasma membrane by a receptor-mediated effect and/or antioxidant property
(Komulainen et al 1999).
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An antioxidant is a molecule that has the capability to neutralise unpaired
electrons from free radical species (Kendall & Eston 2002). A common feature
of these molecules is that they have a carbon-ring structure originating from
phenol species, which have one or multiple hydroxyl groups, allowing for their
ability to reduce electrons (Kendall & Eston 2002). Lipid peroxidation, initiated
by hydroxyl radicals attacking polyunsaturated fatty acids in membranes, can
cause oxidative damage and possibly lead to membrane instability (Kendall &
Eston 2002). Estrogen posses a hydroxyl group on its A (phenolic) ring, which is
in the same position and configuration observed with vitamin E, and thyroxine
(Kendall & Eston 2002). Therefore, estrogen has been speculated as
possessing antioxidant properties as it can potentially donate hydrogen atoms
from the phenolic hydroxyl group and terminate reactions resulting from
peroxidation (Kendall & Eston 2002).
Estrogen is a lipophilic structure and fat-soluble in nature which gives it
membrane stabilization properties (Kendall & Eston 2002; McClung et al
2006). Binding of estrogen to the phospholipid bilayer allows for the possibility of
altering membrane fluidity (McClung et al 2006). Neutrophil, macrophage, and
inflammatory cytokine expression are components of the inflammatory response
which are sensitive to ovarian hormones (Komulainen et al 1999; Tiidus et al
2001; McClung et al 2006; Toumi et al 2006).
It has been proposed that the mechanisms underlying estrogen's
incorporation into cell membranes, would act in a similar fashion as cholesterol,
and act to increase the efficiency of membrane fluidity and arrangement of
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polyunsaturated fatty acids, thereby limiting disruptions to the muscle membrane
after injury (Tiidus 2003). Evidence of estrogen's potential as a membrane
stabilizer is the reduced CK leakage in females and estrogen treated muscle
(Tiidus et al 2001; Tiidus 2003).
There is evidence suggesting estrogen possesses an inhibitory effect on
muscle post-damage leukocyte infiltration (St Pierre Schneider et al 1999;
Tiidus & Bombardier 1999; Stupka & Tiidus 2001; Tiidus et al 2001). With the
use of rats, females demonstrated lower levels of leukocyte infiltration than
males. In fact, male rats supplemented with estrogen 14 days prior to exercise
had similar results as females in that there is an attenuation of neutrophil
infiltration (Tiidus & Bombardier 1999).
Testing for markers of neutrophil infiltration has commonly been
conducted using measurements of MPO activity (Tiidus et al 2001) as MPO
activity resides predominately in neutrophils (Tiidus & Bombardier 1999, Tiidus
et al 2001). Female rats demonstrated reductions in skeletal muscle neutrophil
infiltration as dictated by muscle myeloperoxidase (MPO) activity 24 hours postexercise in comparison to males (Tiidus & Bombardier 1999). Comparatively,
male rats that were administered estrogen for 2 weeks prior to exercise,
demonstrated attenuated muscle MPO activity which resembled results observed
with females (Tiidus & Bombardier 1999).
Attenuation of neutrophil infiltration 1-2 hours post-exercise can be
influenced by estrogen acting as membrane stabilizer, influencing membrane
fluidity

and function

either

by:

1)

Direct

nonspecific

interactions

with

16

phospholipids, or 2) with other membrane components (Tiidus et al 2001;
Tiidus 2003).
Limited

neutrophil

post-damage

infiltration could be explained

by

estrogen's potential of inhibiting calpain activation, and therefore subsequently
decreasing the creation of neutrophil chemoattractant peptides (Tiidus et al
2001; Tiidus 2003). As a result, reduced muscle membrane disruptions can limit
imbalances in calcium homeostasis, and indirectly prevent the up-regulation of
calpain (Tiidus 2003). Tiidus and colleagues demonstrated that estrogen
supplementation did attenuate neutrophil infiltration, MPO, and calpain activity in
the gastrocnemius and plantaris muscles of rats (Tiidus et al 2001).
Besides the attenuation of neutrophil infiltration, females also had a
delayed infiltration of macrophages compared to males (7 and 5 days
respectively) after running exercise (St. Pierre Schneider 1999; Zai et al 2000;
Tiidus 2003).
With ovariectomised rats, macrophage concentrations remained increased
at day 7 of recovery (McClung et al 2006). Phagocytic ED1+ macrophages in
soleus muscle of ovariectomised females were still elevated at day 7 (McClung
et al 2006). ED1+ macrophages do not decline until the completion of tissue
necrosis during reloading recovery (McClung et al 2006). Therefore, prolonged
elevation of ED1+ macrophages indicate delays in the removal of apoptotic
neutrophils and/or continued removal of necrotic myofiber debris (McClung et al
2006). Delays in functions performed by ED1+ could influence the infiltration of
ED2+ macrophages which occurs in the latter portion of ED1+ macrophage
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accumulation in intact muscle and is affected by ovariectomy (McClung et al
2006). It is speculated that alterations in the phagocytosis of necrotic tissue and
muscle regeneration stimulation by macrophage subpopulations may be related
to altered inflammatory signalling (McClung et al 2006).
Estradiol has been demonstrated to play a role in skeletal muscle recovery
following hindlimb suspension in female rats (Moran et al 2006). Failure of
atrophied skeletal muscle to repair itself in ovariectomised rats is attributed to the
reduced activation of Akt-p70s6k signalling pathway, indicating that proteins
involved in initiation of translation are affected by ovarian hormones (Moran et al
2006). Protein synthesis initiation in muscle is governed by the target of
rapamycin (mTOR) of the Akt/mammalian signaling pathway (Glass 2003).
Activating mTOR of p70s6k causes the ribosomal protein S6 to be phosphorylated
which causes an increase in translation of mRNA (Bolster et al 2004). It has
been demonstrated that the Akt/mTOR pathway can be upregulated or
downregulated during periods of muscle growth and muscle atrophy respectively
(Sitnick et al 2006). Synergistic ablation, which is used as a hypertrophic model,
causes increases in activation of Akt and p70s6k however, hypertrophy can be
blocked using rapamyocin (a selective inhibitor of mTOR) (Bodine et al 2001).
Overexpression of p70s6k leads to increases in cell size (Fingar et al 2002) while
removal of p70s6k tends to lead to reductions in muscle mass (Ohanna et al
2005). Therefore, the Akt-mTOR pathway, more specifically p70s6k is implicated
as the possible target for skeletal muscle growth (Sitnick et al 2006) and
circulating estrogens have demonstrated their ability to activate the Akt-mTOR
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signaling pathway in a number of tissues (Patten et al 2004; Pedram et al
2002).
There are several satellite cell markers that are used to help identify
satellite cells in the quiescent, activated, and/or proliferative stages of the cell
cycle. Identification of protein products from muscle regulatory factor genes such
as myf5, MyoD, myogenin, and MRF4 in the nuclei of activated satellite cells, as
well as transcripts of muscle regulatory factors such as MyoD in perinuclear
cytoplasm, can be used to identify satellite cells in both regenerating muscle and
myogenic precursor populations between fibers (Wozniak et al 2005). However,
quiescent satellite cells do not express MyoD and MEF2 myogenic regulatory
factors or any known markers of terminal differentiation (Hawke & Garry 2001).
Research has led to the identification of the paired boxed transcription factor pax7 which is selectively expressed in quiescent and activated satellite cells (Seale
et al 2000; Hawke & Garry 2001). Research focussing on skeletal muscle with
the pax-7 mutation revealed complete absence of satellite cells which suggests,
that pax-7 is essential for specification of satellite cell populations (Seale et al
2000; Hawke & Garry 2001).
The use of pax-7 provides the ability to identify satellite cell activation in
response to tissue injury. Tiidus and colleagues demonstrated that there was an
increase in the number of pax-7 positive satellite cells in soleus and white vastus
muscles in estrogen supplemented male rats compared to unsupplemented male
rats 72 hours post-exercise (Tiidus et al 2005). However, because pax-7, labels
satellite cells that are quiescent, activated, and proliferating (Hawke & Garry
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2001; Enns & Tiidus 2008), it is unclear as to which stage(s) of satellite cell
activation is influenced by estrogen (Enns & Tiidus 2008).
A recent study conducted by Enns and Tiidus revealed increases in the
number of fibers containing activated (MyoD-positive) and proliferating (BrdUincorporated) satellite cells in the estrogen-supplemented groups compared to
the sham group were observed (Enns & Tiidus 2008). The authors speculate
that estrogen exerts its effects upstream of satellite cell activation as differences
between the number of fibers containing activated and proliferating satellite cells
were not observed (Enns & Tiidus 2008).
Even though demonstrated with disuse-induced muscle atrophy in rats,
ovarian hormone loss delays muscle mass recovery in rat skeletal muscle and
therefore implicates estrogen's importance for timely recovery of muscle mass
following disuse atrophy in female rats (McClung et al 2006).
Observations of diminished skeletal muscle contractility following the loss
of ovarian hormones were found in both the soleus and extensor digitorum
longus (EDL) muscle of adult female mice (Moran et al 2007). Muscle function
loss is not due to declines in the contractile protein content, but rather from
alterations in myosin function (McClung et al 2006). More specifically the
proportion of strong-binding myosin during contractions was 15% lower in
muscles from ovariectomised mice compared to controls (Moran et al 2007).
Estradiol has the ability to reverse the effects of ovariectomy-induced
contractile dysfunction indicating that this is a hormone involved in the regulation
of skeletal muscle function in mice (Moran et al 2007). The proposed
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mechanism by which estradiol restores contractility is by increasing the number
of strongly-bound myosin as indicated by electron paramagnetic resonance
(EPR) spectroscopy and active stiffness measurements (Moran et al 2007).
Besides contractile dysfunction, reductions in calcium-activated force have
been observed in the soleus and EDL muscle fibers of -20% following
ovariectomy in rodents (Moran et al 2007). In conjunction, the proportion of
strong-binding myosin heads during contraction was reduced in fibers from
ovariectomised mice (Moran et al 2007). However, ovariectomised-induced
reductions in strong-binding myosin can be reversed with estradiol administration
as measured using EPR spectroscopy, site-directed spin labelling of myosin, and
indirectly by active stiffness measurements (Moran et al 2007). As a result, it is
speculated that myosin is the protein which is affected by estradiol and
responsible for the ovariectomised-induced

reduction

in force-generation

capacity (Moran et al 2007).

1.5 Skeletal Muscle Estrogen Receptors
Small amounts of estrogen receptor alpha and beta (ER-a and -(3)
(Aizawa et al 2008) are present in mouse, rat, and human skeletal muscle
(Harrington et al 2003) suggesting that this tissue is sensitive to estrogen
(Moran et al 2007).
It has been observed that there are certain domains of ERa and ER|3
showing a high degree of similarities, specifically the DNA- and ligand-binding
domains (97% and 60% respectively) where as the similarities at the N terminus
are quite small with only 18% homology (Hall et al 2001).
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Four pathways have been identified for the mode of action undertaken by
estrogen receptors (ER's) and are as follows: 1) classical ligand-dependant, 2)
ligand-independent, 3) DNA binding-independent, and 4) cell-surface (nongenomic) signalling (Hall et al 2001). For the purpose of this review, only
pathways 1 and 2 will be elaborated upon.
The classical ligand-dependant mechanism of ER action is the defining
aspect of class I members of the nuclear steroid/thyroid receptor family for which
ERa and ER(3 are members (Hall et al 2001). Binding of a ligand to the ER
results in conformational changes of the ER causing high affinity binding to
specific DNA response elements (ERE's) located in the regulatory regions of
target genes to either stimulate or repress transcription (Hall et al 2001;
Harrington et a 12006).
It has been accepted that ER's functions can be mediated through
extracellular signals in the absence of estrogen (E2) in a ligand-independent
fashion via phosphoylation of ER by cellular kinases (Hall et al 2001). Findings
which have lent support to a ligand-independent pathway surround the ability of
polypeptide growth factors such as epidermal growth factor (EGF) and insulinlike growth factor-1 (IGF-1) to activate ER and increase expression of ER target
genes (Hall et al 2001). EGF and IGF-1 induce mitogen-activated protein kinase
(MAPK) causing phosphorylation of serine 118 of ERa. Increasing activation
factor-1 (AF-1) activity (Campbell et al 2001) by the (MAPK) pathway treated
with EGF and IGF allows for the receptor to interact with ERa-specific coactivator
p68 RNA helicase and activate target gene transcription (Hall et al 2001). It is
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believed that this process may serve as a way in which to amplify growth factor
pathways and enhance mitogenesis within ER-positive pathways. ER can alter
transcription at certain sites via not binding directly to DNA (Harrington et al
2003). At these sites, ER imposes its effects by joining with transcription factors
such as AP-1 or Sp1 (Harrington et al 2003). Conversely, ER's can transrepress
gene expression by DNA inhibition or the activity of certain transcription factors
such as NFkB which in turn is speculated to cause inhibition of the IL-6 gene
(Harrington et al 2003).
The estrogen/ER pathway has not been fully defined; however, there is
evidence supporting the ER's binding to p85 subunit of Phosphatidylinositol-3OH kinase (PI3K) in a ligand-dependant manner (Lee et al 2005). PI3K is
necessary for estrogen/ER signalling as it activates serine-threonine kinase Akt
by phosphorylation (Lee et al 2005). As Akt modulates the functions of numerous
substrates involved with cell functions, the PI3K/Akt signalling pathway is
responsible for functions such as cell proliferation, cell survival and cell cycle
progression (Lee et al 2005).
Little is known concerning regulation and expression of protein kinase B
(PKB), but it has been identified as a downstream target of PI3K activation
(Coffer et al 1998). It appears that PKB is up-regulated as cells become more
terminally differentiated (Coffer et al 1998).
Physiological effects of estrogen are mediated by the ER which is a
ligand-inducible nuclear transcription factor (Brzozowski et al 1997). Hormone
binding to the ligand-binding domain (LBD) of the ER initiates events leading to
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activation or repression of target genes (Brzozowski et al 1997). Agonists and
antagonists bind the same site within core of the LBD but with different binding
modes as demonstrated by the crystal structures of the ER LBD bound to either
17(3-oestradiol or the antagonist raloxifene at resolutions of 3.1 and 2.6A
respectively (Brzozowski et al 1997).
ER's have been shown to be upregulated during periods of exercise in
animals and humans (Lemoine et al 2002b; Wiik et al 2005) while endurance
elevates the expression of the ER-a gene as observed in the gastrocnemius
muscle (Aizawa et al 2008). Wiik and colleagues also demonstrated that with a
seven-week endurance program, levels of the ERa transcripts were increased
significantly in female rat gastocnemius muscle (Wiik et al 2005).
(
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Diagram 1: Sequence of events that eventually lead to muscle damage.
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Chapter Two
Effects of estrogen receptor activation on
post-exercise muscle satellite cell
proliferation
Purpose of Study
To determine if post-exercise satellite cell activation and proliferation is an
estrogen receptor-mediated event in ovariectomised rats supplemented with and
without estrogen and estrogen receptor agonist PPT.

Hypotheses
1. Estrogen supplementation will result in post-exercise increases in
total/activated and proliferating satellite cells using Pax7 and MyoD as
markers when compared to controls.
2. ER agonist (PPT) administration will yield similar post-exercise results in
satellite cell increases as estrogen supplementation when compared to
controls.

Introduction
It has been well documented that skeletal muscle can incur damage due
to lengthening contractions (Armstrong et a/1991, Frieden & Lieber 1992) and
as a result, a sequence of events occurs to aid in the repair process of muscle
(Armstrong et al 1991). Membrane structures (sarcolemma, t-tubles, and
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plasma membrane) are typically damaged as well as other structural damage
during eccentric contractions, an inflammatory response is elicited. Neutrophils
and macrophages are the primary removers of cellular debris from the area of
damage, as well as aiding the initiation of the repair process. When the area of
damage is cleared of cellular debris, the repair of damaged fibers can commence
which is governed by satellite cells.
Satellite cells reside between the basal lamina and sarcolemma and are
considered myogenic precurser cells (Mauro et al 1961). Unlike other tissues,
adult skeletal muscles are terminally differentiated and as a result muscle growth
and regeneration occur by way of the use of satellite cells (Hawke & Garry
2001). Satellite cells remain in a non-proliferative quiescent state until they are
stimulated to enter the cell cycle (Hawke & Garry 2001). Upon stimulation, such
as myotrauma or overload injury, satellite cells are activated, proliferate, and then
differentiate to either fuse with existing damaged fibers or align and fuse to give
rise to a new fiber (Hawke & Garry 2001). The mechanism(s) by which satellite
cells enter their cell cycle are under the control of a number of factors which
include nitric oxide (NO), hepatocyte growth factor (HGF), and insulin-like growth
factor-1 (IGF-1) (Tatsumi era/1998, Anderson 2000, Machida & Booth 2004).
The influence of estrogen on indices of muscle damage, as well as the
inflammatory

response has been well documented; however, very little

information regarding its influence(s) on the repair process is not as clear. Tiidus
and colleagues attempted to address this question and revealed that in the
presence of estrogen, there was a further marked increase in satellite cells post-
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exercise in both the white vastus and soleus muscles which is significantly
greater than the increase in shams (Tiidus et al 2005). A second study that was
conducted by Enns and colleagues focussed upon satellite cell augmentation in
the presence of estrogen and if muscle estrogen receptors mediate its effects by
supplementing animals with an ER antagonist (ICI 182,780). Their results
revealed observable increases in total, activated, and proliferating satellite cells
in estrogen-supplemented animals compared to shams (Enns & Tiidus 2008).
The aforementioned studies implicate estrogen as being able to influence the
repair process; however, the mechanism(s) by which this is accomplished is still
unclear. One possible explanation is that estrogen can stimulate activation via an
estrogen receptor (ER) mediated event. Mammalian skeletal muscles contain two
subtypes of estrogen receptors: estrogen receptor-a and -(3 (Lemoine et al
2002a, Wiik et al 2003, Kalbe et al 2007) and are upregulated with exercise
training (Lemoine ef al 2002b, Wiik et al 2005). There a number of intracellular
signalling pathways that estrogen receptors regulate which includes the
phosphatidyliositol-3 kinase (PI3K)/protein kinase B (Akt) pathway. The PI3K/Akt
pathway is involved in the regulation of cell functions which include cell
proliferation, cell survival, and cell cycle progression (Coffer et al 1998, Lee et al
2005, Patten ef al 2004, Sitnick et al 2006).
Based on previous research (Tiidus ef al 2005, Enns & Tiidus 2008) in
conjunction with what is known regarding the PI3K/Akt pathway, it is possible that
estrogen's ability to increase satellite cell populations is mediated via estrogen
receptors.
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The premise of the current study stems from a study conducted by Enns
and colleagues whereby they investigated if post-exercise increases in satellite
cells were mediated via estrogen receptors (Enns ef a/ 2008). With the aid of an
estrogen receptor antagonist (ICI 182,780), they revealed that in the presence of
the antagonist, any effects exercise and/or estrogen had on increasing satellite
cells was completely abolished (Enns ef a/2008).
For the current study an estrogen receptor-alpha (ER-a) agonist,
propylpyrazole triol (PPT), was employed to elucidate the role of estrogen
receptors in the activation of satellite cells in ovariectomised rats supplemented
with and without estrogen. PPT is an agonist which specifically binds the
estrogen receptor-alpha (ER-a) subtype with a 410-fold greater affinity than that
of ER-p (Harris ef a/ 2002, Stauffer ef a/ 2000). The effects of estrogen and
PPT administration on satellite cell activation was studied using the soleus
(primarily type-l fiber) and white vastus (primarily type-ll fiber) muscles. Pax7 and
MyoD were used as markers of satellite cell activation and proliferation
respectively. Besides quantifying satellite cells, ^-glucuronidase activity was
measured to provide an indirect marker of muscle damage.
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Methods & Materials
Animals: Ovariectomised female Sprague-Dawley rats are used with their
ovaries surgically removed at approximately 9 weeks of age, and arrived at the
lab approximately 10 weeks old. Rats were housed 2 per cage on a 12:12
light/night cycle while food and water are given freely in the Animal Care Facility
(ACF).

Experimental Protocol: Rats were assigned randomly to treatment groups after
one week of acclimation in the ACF. Surgeries performed were as follows: shams
(sham procedure), estrogen (receive estrogen pellet), agonist (receive agonist
injection), estrogen and agonist (receive estrogen pellet and agonist injection).
Each group was then further subdivided into either exercise or non-exercise
groups.
Estrogen supplementation was accomplished using subcutaneous pellet
implantation. Estrogen pellets were 0.25mg of 17(3-estradiol with a 21-day time
release (Innovative Research of America, Sarasota, FL).
The ER-a agonist, 4,4',4"-(4-Propyl-[1H]-pyrazole-1,3,5-triyl) trisphenol
(PPT), (Tocris Cookson Inc., Ellisville, MO, USA), was dissolved in dimethyl
sulfoxide (DMSO) and injected subcutaneously. Animals were injected with PPT
(0.5mg of PPT dissolved in 0.1ml of DMSO) or placebo (DMSO) commencing
approximately 3 days post-surgery for a duration of 6 days.
Under aseptic conditions, estrogen pellet implantation and shams are
performed on rats first anaesthetized by isoflurane inhalation. Estrogen
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supplemented rats had a small incision in the skinfold of their necks, their skin
separated from fascia with blunt dissection and pellet insertion ~ 1cm from
incision site. Shams under went the same procedure performed without pellet
insertion. Incisions were sealed using Vetbond (3M, St. Paul, MN). Recovery
time was approximately 9 days from surgery to tissue collection. Recovery time
allowed for the pellet-implanted group to receive prolonged exposure to estrogen.
Familiarization of the animals to the motorized rodent treadmill (Columbus
Instruments,

Columbus,

OH)

was

conducted

3-4

days

after

surgery.

Familiarization sessions were performed twice for five minutes (once on each of
the succeeding 2 days before engaging in the full exercise protocol). The
exercise protocol involved the animals running downhill intermittently (Run:
5mins, Rest: 2mins) for a total of 90 minutes of running time. The speed of the
treadmill was set to 17m/min at an incline/decline of -13.5° grade (Komulainen
et al 1994). This exercise protocol has been proven to be non-fatiguing, but able
to elicit sufficient/significant damage in soleus and white vastus muscles
(Armstrong et al 1983, Han et al 1999).

Tissue Collection: Animals were sacrificed 72 hours post-exercise by way of an
overdose of sodium pentobarbital (55mg/kg). Blood samples, uterus, soleus and
superficial (white) portions of vastus muscles were removed. Controls (nonexercisers) were sacrificed at the same time points as exercisers.
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Blood samples were collected from the femoral artery, allowed to clot at
room temperature, centrifuged at 3000g's for 10 minutes, and serum removed
and stored at -20°C.
Muscle samples were rinsed in saline, blotted dry and trimmed of
connective tissue and blood vessels. Samples used for immunohistochemical
analysis were mounted on a specimen holder coated in Optimal Cutting
Temperature (OCT) medium (Tissue-Tek, Torrance, CA) and frozen in
isopentane (previously cooled in liquid Nitrogen). Samples used for enzyme and
protein analyses were frozen immediately in liquid nitrogen and stored at minus
20°C until analysis. Timeline and sequence of experimental events (such as
pellet implantation, running program, sacrifice, etc) are depicted in diagram 2.

Serum Analysis: Serum estrogen levels were determined in duplicate using a
commercially produced radioimmunoassay kit (Coat-a-Count TKE21, Inter
Medico, Markham, ON).

Beta-Glucuronidase Activity: Lysosomal acid hydrolase, beta-glucuronidase,
activity was measured in the white vastus and soleus muscles using the method
described by Koskinen et al (2001). Samples were assayed in triplicate at
420nm and activities expressed as the amount of substrate (5mM p-nitrophenylbeta-D-glucuronide, Sigma-Aldrich) hydrolyzed per incubation time and amount
of protein, while the protein concentration was measured using the method of
Lowry (Lowry et al 1951).
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Immunohistochemical

Procedures: Immunohistochemical procedures and

quantification were performed as previously described (Enns et al 2008, Enns &
Tiidus 2008). Transverse serial sections of soleus and white vastus were cut
10um in thickness using a cryostat (Leica CM3050S) at -20°C. Sections were
mounted on glass slides treated with vectabond (Vectabond Laboratories,
Burlington, ON), dried at room temperature and stored at -20°C. Sections were
immunostained for markers of total (Pax7), and activated (MyoD). All samples
were fixed with cold (4°C) acetone for 10 minutes while endogenous peroxidases
were inactivated with 0.6% hydrogen peroxide in absolute methanol, followed by
3 washes in 15mM phosphate-buffered saline (PBS, pH 7.6). Nonspecific sites
were blocked for 30 minutes using 5% normal goat serum in PBS (containing 5%
nonfat milk powder).
Pax7 immunostaining was accomplished by the slides being incubated
with an antibody specific to Pax7 (Developmental Studies Hybridoma Bank,
University of Iowa, Iowa City, IA) for 40 minutes at a dilution of 1:20, while with
MyoD immunostaining, slides were incubated overnight at 4°C in an antibody
specific for MyoD (Dako Canada, Mississauga, ON) at a 1:50 dilution.
After 3 rinses in PBS, slides were developed using commercially available
kits (LSAB-2, Dako Canada) which contain universal biotinylated secondary
antibody and streptavidin-conjugated horseradish peroxidase. Satellite cells were
visualized using NovaRed (Pax7) (Vector Laboratories) or diaminobenzidine
(DAB) with

nickel (MyoD) (Vector

Laboratories). All slides were then
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counterstained using hematoxylin QS (Vector Laboratories) and mounted using
permanent mounting medium (Vector Laboratories).
Quantifying satellite cells encompassed the slides being put under a light
microscope (Leica DMLS) and having the image projected onto a computer
screen at a 400x magnification (10x ocular and 40x objective lens). Satellite cells
were identified via oval-shaped dark blue bodies with red coloured edges located
in the vicinity of the sarcolemma.
A total of 400 myofibers were counted from two individual sections from
each muscle sample (200 fibers per section x 2 sections). The relative number of
myofibers positive for each marker (Pax7 or MyoD) are calculated as the:
[number of positive fibers / 400 x 100%].

Statistical Analysis: All data obtained is presented as means ± SD. In order to
assess any differences between groups, a one-way analysis of variance
(ANOVA) at a level of significance of p < 0.05 was employed. Situations whereby
significance is found, post-hoc testing by way of the LSD test was used to
evaluate specific differences between groups.
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Outline of experimental design. Exercise = exercised
condition; Non-exercise = unexercised (control) condition

Arrival of animals

Surgeries performed in second week after arrival;

PPT injections commenced 3 days post-surgery for a duration of 6 days.

Running protocol performed 1; week post-surgery.

3 days ptosfr-exercise, tissue collection performed,;

Diagram 2: Timeline of experimental protocol. Sequence and timing of
events.
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Results
Serum Estrogen Levels
Neither exercise nor time of sacrifice had any bearing on serum estrogen
levels, therefore animals were grouped according to the treatment condition to
which they were assigned (sham, estrogen-supplemented, PPT-supplemented,
estrogen and PPT-supplemented).
As to be expected, figure 2 and table 1 illustrate that the group
supplemented with estrogen had a significantly higher (p < 0.05) estrogen serum
levels compared to both the sham and PPT-supplemented groups. However,
there was not a significant difference (p > 0.05) between the groups
supplemented with estrogen and both estrogen and PPT.

Body Weights
All animals progressively gained weight during the experimental time
period. Upon the day of sacrifice, animals in the sham treatment group were
significantly greater (p < 0.05) in weight than those treated with estrogen, PPT, or
both estrogen and PPT. There was not a significant difference (p > 0.05)
observed

when

comparing

estrogen-supplemented

animals

with

those

supplemented with PPT or estrogen and PPT (Table 1 & Figure 3).

Uterine Weights
When binding of estrogen to uterine estrogen receptors occurs, this
results in the stimulation of uterine growth. As a result, PPT (an ER-alpha
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agonist) would mimic the effects of estrogen and cause increases in uterine
weight when bound to uterine estrogen receptors.
Table 2 as well as figure 4 and 5 depicts that sham animals had
significantly lower (p < 0.05) uterine wet weights in comparison to all other
treatment groups (estrogen, PPT, estrogen and PPT). Conversely, animals
supplemented with both estrogen and PPT not only had a significantly greater (p
< 0.05) uterine weights than shams, but also with the groups supplemented with
estrogen or PPT alone.

^•Glucuronidase Activity
Lysosomal acid hydrolase, beta-glucuronidase, activity was used as an
indirect marker of muscle damage incurred during the downhill running protocol.
The soleus muscle did reveal a significant difference (p < 0.05) for both exercise
and treatment condition (Table 3). Exercised rats were observed to have a
significantly greater (p < 0.05) (3-glucuronidase activity compared to controls
while the group treated with estrogen and PPT had a significantly lower (p <
0.05) post-exercise ^-glucuronidase activity with respect to all other treatment
conditions (shams, estrogen, PPT). Animals that were either estrogen- or PPTsupplemented also demonstrated a significantly lower (p< 0.05) post-exercise (3glucuronidase activity when compared to shams. These trends that were
observed with the soleus muscle were not clearly demonstrated with the white
vastus muscle. The data obtained for the white vastus muscle did not
demonstrate significant increases in muscle damage with exercise or, reductions
in (3-glucuronidase activity when in the presence of estrogen and/or PPT.
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Therefore, this discrepancy in the results obtained for the white vastus muscle
posses as a limitation of the study due to the fact that, no muscle damage was
observed while there were significant increases in satellite cell activation and
proliferation. Previous studies (THdus & Bombardier 2005; Enns & Tiidus
2008; Enns et al 2008) using the same exercise protocol as was used for the
current study, have clearly indicated the changes on post-exercise (3glucuronidase activities.

Satellite Cell Activation
The identification of satellite cells that have been stimulated to enter their
cell cycle is accomplished by using Pax7 and MyoD as markers. The number of
muscle fibers that stain positively for Pax7 (total/activated satellite cells) and
MyoD (proliferating satellite cells) are depicted in figures 6-9.
The running protocol that the animals underwent elicited a significantly
greater (p < 0.05) number of fibers staining positively for total/activated, and
proliferating satellite cells in both the white vastus and soleus muscles compared
to controls. These increases in satellite cells due to the exercise protocol were
observed 72 hours post-exercise in all treatment conditions (sham, estrogen,
PPT, estrogen & PPT).
It was observed that animals supplemented with estrogen and/or PPT had
significantly greater (p < 0.05) number of fibers staining positively for Pax7 and
MyoD in both the soleus and white vastus muscle when compared to shams.
There were no significant differences (p < 0.05) between the estrogen, PPT, and
estrogen & PPT post-exercise satellite cell counts.
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Table 1: Animal body weights and serum estrogen levels for sham, estrogen, PPT, and
estrogen & PPT treatment groups. Values were grouped as means ± SD.
a
p < 0.05 compared to shams.
Treatment
Sham
Estrogen
PPT
Estrogen &
PPT

Serum Estrodiol (pg.mg"1)
11.3 ±3.6
92.1 ± 70.8a
12.7 ±3.7
78.2 ± 42.7a

Body Weight (g)
310.59 ±13.07
267.69 ± 11.51a
277.72 ± 9.50a
259.12 ±9.66 a

»180.0
i= 160.0

J? 140.0
"» 120.0 J
" 100.0
a> 80.0
o>
o 60.0
*->

40.0
20.0
0.0
CO

Sham

Estrogen

PPT

Estrogen & PPT

Treatment Condition
Figure 2: Serum estrogen levels for sham, estrogen, PPT, and estrogen & PPT
treatment groups. Values were grouped as means ± SD.
a
p < 0.05 compared to shams.
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Figure 3: Animal body weights for sham, estrogen, PPT, and estrogen & PPT
treatment groups. Values were grouped as means ± SD.
p < 0.05 compared to shams.

Table 2: Changes in uterine weights. Values were grouped as means ± SD.
a
p < 0.05 compared to shams.
b
p < 0.05 compared to estrogen-supplemented group.

Sham

Estrogen

PPT

Estrogen &
PPT

Wet Weight, g

0.1102 ±0.035

Wet Weight, g
100g"1 body
weight

0.0350 ±0.013

0.4087 ±
0.064a
0.1481 ±
0.041 a

0.3325 ±
0.070a
0.1194 ±
0.024a

0.3254±
0.084ab
0.1875 ±
0.057ab
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Figure 4: Uterine weights at time of sacrifice. Values were grouped as means ±
SD.
a
p < 0.05 compared to shams.
b
p < 0.05 compared to estrogen-supplemented.

«,

0.30

.E>

0.25

ab

<u
a

^ 0 . 2 0 <D CO

a

• S I 0.15-

_

<D " *•* o > ~

^^^^^^^H

^^^^^^^B

^^H
^ ^ ^ |

^^^|

^^^^H

.-

=>—0.10
CD
CD
CTI
CD
CD
CD

Relativ

<D

•1
Sham

•

Estrogen

|

^^H

•

PPT

i

Estrogen &
PPT

Treatment Condition
Figure 5: Relative uterine weights at time of Sacrifice. Values were grouped as
means ± SD.
a
p < 0.05 compared to shams.
b
p < 0.05 compared to estrogen-supplemented.
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Table 3: (3-glucuronidase activity in the white vastus and soleus. Values are
listed as means ± SD.
a
p < 0.05 compared to controls.
b
p < 0.05 compared to shams.

White Vastus
Control
Exercise

Sham

Estrogen

PPT

Estrogen &
PPT

2.44 ± 0.95
2.47 ± 0.82

2.10 ±0.95
2.78 ± 0.62

3.39 ±1.31
3.15 ±0.92

2.70 ±1.08
3.42 ±1.07

4.70 ± 0.97
7.19±2.61 a

4.56 ± 0.58
6.04 ± 2.83aD

5.21 ± 0.50
5.55±1.01 a b

3.99 ± 0.83
4.42 ± 0.96ab
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Exercise
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Figure 6: Effects of estrogen- and PPT-supplementation on expression of MyoD
satellite cells in rat white vastus muscle 72 hours post-exercise.
Values are listed as means ± SD.
a
p < 0.05 compared to controls.
b
p < 0.05 compared to shams.
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Figure 7: Effects of estrogen- and PPT-supplementation on expression of MyoD
satellite cells in rat soleus muscle 72 hours post-exercise. Values are
listed as means ± SD.
a
p < 0.05 compared to controls.
b
p < 0.05 compared to shams.
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Sham
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PPT
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Treatment Condition
Figure 8: Effects of estrogen- and PPT-supplementation on expression of Pax7
satellite cells in rat white vastus muscle 72 hours post-exercise.
Values are listed as means ± SD.
a
p < 0.05 compared to controls.
b
p < 0.05 compared to shams.
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Figure 9: Effects of estrogen- and PPT-supplementation on expression of Pax7 satellite
cells in rat soleus muscle 72 hours post-exercise. Values are listed as means
±SD.
a
p < 0.05 compared to controls.
b
p < 0.05 compared to shams.
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Discussion
Uterine & Body Weights
Propyl pyrazole triol (PPT) is a highly selective, synthetic ER-a agonist
developed by Harris et al (2002) which has a 410-fold greater affinity for ER-a
than ER-(3 (Harris et al 2002). Therefore, PPT's selectivity towards the ER-a
subtype, renders it unable to activate ER-|3. Results obtained by Harris et al
(2002) seem to be consistent with the uterus predominantly expressing ER-a
(Harris et al 2002) while with the use of ERaKO mice, there was an inability to
stimulate uterine weight gain when in the presence of estrogen (Couse et al
1995). The aforementioned results leads to the idea that ER-a is necessary for
the activation of a full uterotrophic response while ER-|3 is not required for these
estrogenic effects (Harris et al 2002).
For the purpose of the current study, uterine wet weights were measured
to verify ovariectomy was performed, as well as to provide an indirect measure of
global ER saturation. PPT was able to effectively bind to the ER-a's and cause
significant increases in uterine wet weights in relation to shams.
In agreement with previous studies by Enns & Tiidus (2008); Enns et al
(2008); and Iqbal et al (2008) estrogen- and/or PPT-supplemented animals had
significantly lower body weights in comparison to shams while there was no
significant difference observed between the estrogen- and PPT-supplemented
groups. Reductions in body weight observed in the PPT-supplemented group
was to be expected as illustrated by the idea that binding of the ER-a (in this

44

specific case, by PPT) is capable of decreasing food intake, meal size, and body
weight in OVX rats (Santollo et al 2007).

Serum Estrogen Levels
Significant increases in serum estrogen levels were observed in the
estrogen-supplemented groups compared to shams. These increases were
seven- and eight-fold greater than that of the shams for the estrogen- and
estrogen & PPT-supplemented treatment groups respectively while these groups
showed no significant difference between each other.
A wide range of serum estrogen levels have been reported in the past in
regards to ovariectomised rats receiving estrogen supplementation. Serum
estrogen values range from as low as 15-20pg/ml (Persky et al 2000) and as
high as 285pg/ml (McNulty et al 2000). However, even though a wide range of
values have been reported regarding estrogen-supplementation of OVX rats, the
values ascertained in the current study are similar to previous studies (Enns et al
2008; Iqbal et al 2008). The variability of serum estrogen levels reported could
be influenced by age and stage of estrus cycle of the animals (Enns et al 2008).
Beta-Glucuronidase
Measurement of muscle beta-glucuronidase activity was performed to
provide indirect evidence of post-exercise muscle damage incurred by our
running protocol. Previous research (Komulainen et al 1999; Salmien 1985)
has demonstrated that beta-glucuronidase to be a reliable marker of postexercise muscle damage. Results of the current study are consistent with
previous studies (Enns & Tiidus 2008; Enns et al 2008) in that there was an
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attenuation of beta-glucuronidase activity in the groups supplemented with
estrogen. There was no significant difference between the treatment groups
supplemented with estrogen, PPT, and estrogen & PPT. In light of the
aforementioned point and in conjunction with Enns et al (2008) observing no
difference between estrogen- and estrogen & antagonist-supplemented groups,
one might consider the idea that reduction in beta-glucuronidase activity is not an
ER-mediated event.
Satellite Cells
The primary objective of this study was to determine if ER's play a role in
the post-exercise activation/proliferation of satellite cells by using an ER-a
agonist, PPT. Previous studies have demonstrated that estrogen does influence
post-exercise satellite cell numbers (Tiidus et al 2005; Enns & Tiidus 2008;
Enns et al 2008). However, the mechanism(s) by which estrogen stimulates
satellite cells to become activated have yet to be elucidated.
The premise of the current study stems from results yielded by Enns et al
(2008) whereby they blocked the activity of ER's using an ER antagonist ICI
182,780. They revealed that when in the presence of ICI 182,780, effects of
estrogen and/or exercise on increases of satellite cell numbers were completely
abolished. The data collected during the aforementioned study implicates
satellite cell activation is an ER-mediated event. Therefore, in the presence of an
ER-a agonist (PPT), it is speculated that satellite cell activation and proliferation
would yield similar results to that observed with estrogen in the white vastus and
soleus muscles.
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The findings of the current study revealed that there were significant
increases in fibers staining positively for markers of satellite cell activation (pax7) and proliferation (MyoD) 72 hours post-exercise.
The groups supplemented with estrogen and/or PPT yielded similar
results when compared to shams. The observance of a non-significant difference
between groups supplemented with estrogen and/or PPT can be explained by
the notion that mammalian skeletal muscle contains both ER-a and ER-(3 (Wiik
et al 2003); however, skeletal muscle contain relatively fewer ER's than that of
other tissue (Katzenellenbogen et al 1995). Therefore, with the small numbers
of ER's present in skeletal muscle, saturation of the ER-a's can be accomplished
when in the presence of estrogen and/or PPT. The data obtained from this study,
as well as in conjunction with what was observed by Enns et al (2008), allude to
the idea that ER's (more specifically, ER-a) plays a role upstream of the
activation of satellite cells. Therefore, the mechanism(s) by which ER-a's
stimulate satellite cell activation is speculated to be under the control of the
phosphatidylinositol 3-kinase (PI3K) pathway which is involved with ER signalling
when ER's are bound by estrogen (Campbell et al 2001). ER's have the ability
to bind the p85 regulatory subunit of the PI3K pathway in a ligand-dependant
manner (Simoncini et al 2000) which causes this pathway to become activated
and eventually leading to the phosphorylation of AKT (Coffer et al 1998). AKT is
responsible for modulating a number of substrates that aid in the regulation of
cell functions which include cell proliferation, cell survival, and cell cycle
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progression, as depicted in diagram 3 (Vanhaesebroeck et al 2001; Coffer et al
1998; Gaven et al 2004).
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Diagram 3: Schematic of the PI3K/Akt pathway depicting the substrates
Akt modulates which aid in the regulation of cell functions.
(Cell Signaling Technology 2009).
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Chapter Three
Discussion & Conclusion
It has been well documented that estrogen influences the muscle damage
and repair process. Estrogen has been demonstrated to affect creatine kinase
levels and (3-glucuronidase activity which are typically used as indirect markers of
post-exercise skeletal muscle damage. In the presence of estrogen, the
aforementioned markers are considerably reduced when compared to controls
(Armstrong et al 1983; Komulainen et al 1999). Therefore, the data lends itself
to the idea that estrogen can act as a potential membrane stabiliser and/or
antioxidant. In conjunction with affecting the magnitude of post-exercise muscle
damage, estrogen plays a role in the alterations of leukocyte infiltration (namely
neutrophils and macrophages) in response to skeletal muscle injury. Studies
conducted in our lab have consistently demonstrated that when in the presence
of estrogen, there is an attenuation in leukocyte infiltration (Tiidus
Bombardier

&

1999; Enns et al 2008; Iqbal et al 2008) and calpain (or at least

calpain-like) activity (Tiidus et al 2001).
Besides influencing indices of post-exercise skeletal muscle damage (as
determined by the markers CK and (3-glucuronidase) as well as leukocyte
infiltration, estrogen has been implicated in influencing the activity of cytokines
such as NO, HGF, and IL-6. The aforementioned cytokines have been observed
to contribute to the activation of satellite cells. IL-6, which is produced by a
number of cells which include myoblasts and macrophages, aids in degrading
necrotic tissue, synchronization of the satellite cell cycle, and macrophage
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apoptosis after muscle injury (Hawke & Garry 2001). However, estrogen has
been identified to down regulate IL-6 activity at the IL-6 promoter (Pottratz et al
1994). NO has the potential to be influenced by estrogen during periods of
muscle injury (Simoncini et al 2002; Prorock et al 2003). Nitric oxide synthase
(NOS) and NO levels are increased when in the presence of estrogen and may
have an effect on the muscle damage and repair process (Caulin-Glaser et al
1997; Node et al 1997). NO has also been identified in influencing HGF, a
known regulator of satellite cell regulation (Tatsumi et al 1998), and its release
and localisation is a NO-dependant process during periods of muscle injury
(Tatsumi et al 1998).
It has been demonstrated that estrogen may influence the skeletal muscle
repair process. A recent study conducted in our lab revealed that estrogen
supplemented rats had an elevated number of fibers containing total, activated,
and proliferating satellite cells (Enns & Tiidus 2008). Therefore, estrogen seems
to have a dual function in regard to attenuating indices of post-exercise skeletal
muscle damage but, it also positively influences the repair process by activating
satellite cells. To further understand and expand upon the research conducted by
Enns & Tiidus (2008), they attempted to explore the role estrogen receptors
may have on facilitating the activation of satellite cells. Enns et al (2008) blocked
the ER's using an ER antagonist (ICI 182,780) to aid in determining if ER's were
an upstream contributor to satellite cell activation. It was observed that in the
presence of ICI 182,720, any effect estrogen and/or exercise had on postexercise satellite cell numbers was completely abolished (Enns et al 2008). This
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novel finding was the first study to allude to the idea that satellite cell activation is
an ER-mediated event (Enns et al 2008). The mechanism(s) of ER's ability to
aid in satellite cell activation is still unclear however, the data collected by Enns
et al (2008) allowed for the current study to attempt answering the question, "is
satellite cell activation an ER-mediated event." The current study attempted to
address the aforementioned question using an ER-a agonist (PPT) rather than
the antagonist.
Propyl pyrazole triol (PPT) is a highly selective, synthetic ER-a agonist
developed by Harris et al (2002) which has a 410-fold greater affinity for ER-a
than ER-(3 (Harris et al 2002). Therefore, PPT's selectivity towards the ER-a
subtype, renders it unable to activate ER-(3. The current study revealed that when
in the presence of the ER-a agonist, PPT, there was a significant increase in the
number of fibers staining positive for activated and proliferating satellite cells
when compared to shams. Due to observing no significant difference between
the PPT- and estrogen-supplemented treatment conditions, there seems to be
evidence to support the notion that ER-a is responsible for most, if not all of the
activation of satellite cell activity when bound by estrogen.
There seems to be evidence suggesting estrogen and ER's may regulate
biological processes via different pathways (Hall et al 2001). It is believed that
ER's bound by estrogen can either bind directly to estrogen response elements
(ERE's) which are located in the promoter regions of target genes or, can interact
with other transcription factor complexes such as Fos/Jun (AP-1 responsive
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elements) to initiate transcription of genes not containing ERE's in their promoter
regions (Heldring et al 2007).
It has been speculated that a potential mechanism by which ER-a's exert
their effects is via the PI3-K pathway. The PI3-K pathway has been identified as
being responsible for functions such as cell proliferation, cell survival, and cell
cycle progression (Lee et al 2005).
Besides ER's exerting their effects when bound by estrogen, ER's have
the ability to function when estrogen is not present. Epidermal growth factor
(EGF) and insulin-like growth factor (IGF-1) have been identified to stimulate
ER's causing increases in the expression of ER target genes (Hall et al 2001). It
is speculated that when levels of estrogen are low, as seen with males, that
hormone-independent pathways can allow for ER activation (Hall et al 2001).
With what is known regarding the role ER-a's may have on the skeletal
muscle repair process, it can be speculated as to the potential applicability of this
area of research. Studies have demonstrated that exercise alters satellite cell
content, and satellite cell content varies between histochemically and functionally
different muscles, as well as in individuals with differing physical activity levels
and ages (Kadi et al 2004). Older individuals for example, typically have reduced
satellite cell populations as a result of age (Kadi et al 2005). However, human
studies have revealed that not only are satellite cells maintained with exercise
training, but are enhanced (Kadi et al 2005). In conjunction with exercise,
estrogen has demonstrated its ability to influence satellite cell pools (Tiidus &
Bombardier 2005; Enns & Tiidus 2008) and now, in light of the current study as
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well as the study conducted by Enns et al (2008), it is revealed that estrogen's
effects are mediated through the ER (more specifically ER-a). With this
information, individuals who suffer from conditions such as sarcopenia, or who
are postmenopausal can be the eventual target populations for this line of
research. Sarcopenia is an age-related condition depicted by progressive
declines in muscle mass and quality (Lee et al 2007; Hameed et al 2002).
Therefore, understanding the mechanism(s) that lead to satellite cell renewal can
aid in at least offsetting age-related declines in muscle mass, quality, and
atrophy.
In regards to postmenopausal females, there is a reduction in the amount
of circulating estrogen present. However, data collected from older females have
indicated that higher serum estrogen concentrations are associated with
increased muscle mass and strength (Rokainen et al 2009), while losses of 1525% of total muscle strength (in addition to strength declines associated with
ageing) seems to coincide with menopause (Onambele et al 2006).
The aforementioned data alludes to the idea that low levels of estrogen is
potentially responsible for age-related muscle weakness and altered muscle
composition (Rokainen et al 2009). There seems to be evidence of an agegender interaction as postmenopausal women demonstrate significant increases
in post-exercise muscle damage when compared with younger females and
males, respectively (Roth et al 2000).
Ronkainen et al (2009) investigated the effects long-term hormone
replacement therapy (HRT) would have on mobility and skeletal muscle mass,
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composition, and function in postmenopausal women 54-62 years of age
(Ronkainen et al 2009). They revealed that HRT was associated with better
mobility and greater muscle power, while individuals in the HRT treatment group
had a lower relative proportion of fat within the muscle, as well as having larger
muscles when compared to controls (Ronkainen et al 2009).
The current study demonstrated that with the use of an ER-a agonist,
similar results were yielded when compared to the estrogen-supplemented group
in regards to satellite cell activation. The ER-a agonist used in this study (PPT)
not only can influence satellite cell populations, but can also influence symptoms
experienced by postmenopausal females.
Postmenopausal females tend to experience hot flashes, and as a result,
may choose to undergo hormone replacement therapy (HRT). However, data
collected

by Harris

et al (2002) revealed

PPT's ability to

attenuate

experimentally induced hot flashes in rats (Harris et al 2002).
It can be summarized that ER-a is implicated as being responsible for
most, if not all, of the activation of satellite cell activity when bound to estrogen.
The applicability of the data collected in the current study may eventually lead to
synthesizing estrogen analogs that can interact with ER-a's to aid with postexercise skeletal muscle repair process.
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Appendix A
PAX 7 Immunohistochemistry
Use frozen sections of rat muscle cut 7-10 microns thick.
1.
2.
3.
4.
5.
6.
7.
8.

Let slides air dry for 5 min or until warmed up to room temperature.
Fix sections with 100% cold acetone for 10 min.
Let slides air dry for 5-10 min.
Permeablize cells in 0.5% Triton X-100 solution (in PBS) for 5 min.
Wash in PBS f o r 3 x 5 min.
Apply 0.6% H2O2 (in absolute methanol) for 10 min.
Wash in PBS for 3 x 5 min.
Block with 5% normal goat serum in PBS (containing 5% nonfat milk powder)
for 30 min. Tap off excess.
9. Incubate in primary antibody: Pax 7 (1/20 diluted in blocking solution) for 1 h.
10. Wash in PBS for 3 x 5 min.
11 .Apply bottle 3: GAM-Biotin (from Dako LSAB-2 kit) for 10 min.
12. Wash in PBS for 3 x 5 min.
13. Apply Bottle 4: Streptavidin-HRP (from Dako LSAB-2 kit) for 10 min.
14. Wash in PBS for 3 x 5 min.
15. Apply Vector NovaRed stain for 5 min (or until desired intensity is achieved).
16. Rinse in dH 2 0 liberally from wash bottle, then wash in bath for 2 x 5 min.
17.Counterstain using Vector Hematoxylin QS (add hematoxylin for 10-15 s and
rinse off with running 37°C tap water for 30 s).
18. Place a drop of permanent mounting medium on cover slip and place slide
upside down onto cover slip so that mounting medium covers section
completely.
19. Invert slide and apply gentle pressure on cover slip to remove any air
bubbles.

Notes:
*
*
*

All kit reagents should be equilibrated to room temperature prior to
procedures and all incubations are done at room temperature
Place all buffer baths on rocker for gentle agitation
Pax 7 stock solution does not have anything in it to fight bacteria, so use
sterile technique
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Appendix B
MyoD Immunohistochemistry
Use frozen sections of rat muscle cut 7-10 jam thick.
1.
2.
3.
4.
5.
6.
7.
8.

Let slides air dry for 5 min or until warmed up to room temperature.
Fix sections with 100% cold acetone for 10 min.
Let slides air dry for 5-10 min.
Permeablize cells in 0.5% Triton X-100 solution (in PBS) for 5 min.
Wash in PBS for 3 x 5 min.
Apply 0.6% H 2 0 2 (in absolute methanol) for 10 min.
Wash in PBS for 3 x 5 min.
Block with 5% normal goat serum in PBS (containing 5% nonfat milk powder)
for 30 min. Tap off excess.
9. Apply primary antibody: MyoD (DakoCytomation, 1/50 diluted in blocking
solution) overnight at 4°C (in humidity chamber).
10. Wash in PBS for 3 x 5 min.
11 .Apply bottle 3: GAM-Biotin (from Dako LSAB-2 kit) for 10 min.
12. Wash in PBS for 3 x 5 min.
13. Apply Bottle 4: Streptavidin-HRP (from DakoLSAB-2 kit) for 10 min.
14. Wash in PBS for 3 x 5 min.
15. Apply DAB stain (Vector Laboratories) for 5 min (or until desired intensity is
achieved).
16. Rinse in dH 2 0 liberally from wash bottle.
17. Counterstain using Vector Hematoxylin QS (add hematoxylin for 15 s and
rinse off with running tap water for 30 s).
18. Place a drop of permanent mounting medium on cover slip and place slide
upside down onto cover slip so that mounting medium covers section
completely.
19. Invert slide and apply gentle pressure on cover slip to remove any air
bubbles.

Notes:
*
*

All kit reagents should be equilibrated to room temperature prior to
procedures and all incubations are done at room temperature
Place all buffer baths on rocker for gentle agitation
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Appendix C
^-Glucuronidase Enzyme Assay
1. Homogenize tissue (10-20 mg; optimal 15 mg) in glass pestle using a
33.33:1 (3%) dilution using distilled water.
-use 16.66667 times the mass of tissue, do this 2 times
-turn on hot water bath to 37°C, to get it warmed up
2. Add 50 |J of homogenate and water to appropriately labeled test tube
-use 12x75mm glass culture tubes
-freeze remaining homogenate and use for Lowry protein analysis
3. Add 450 [i\ of Acetate buffer to tubes using repeater pipette
4. Preincubate tubes in 37°C bath for 5 minutes
-place parafilm over rack so water doesn't drip in
5. Add 250 jutl of substrate using repeater pipette
6. Incubate for 16-18 hours
-cover the rack with parafilm
-must sit overnight... so make sure that you plan the timing
**record the exact time that the samples came out of the water
bath, the total incubation time in seconds is needed in the
calculation**
7. Add 1.5 ml of cold glycine buffer using repeater pipette
-turn on centrifuge when first get in, in the morning so it can cool
down
-make up the day before and refrigerate because must be cold
8. Cool in ice water for 10 minutes
-fill the sink with cold water, deep enough to cover the solution in
the tubes, add a few ice cubes to keep cold
-turn on computer, select CaryWinUV program and set up for
Simple Reads (make sure wavelength is 420 nm)
9. Centrifuge at 3500 rpm for 10 minutes (temp 4°C)
-samples must be poured into micro centrifuge tubes in order to go
in the centrifuge
10. Read on spectrophotometer at 420 nm.
-pipette approx 1 ml from tube, avoiding the pellet on the bottom,
and put in a 2 sided clear, skinny cuvette
-vacuum out cuvettes between samples
-use the same cuvette throughout, but rinse with distilled water
between the most concentrated standard and the first sample
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Appendix D
Lowry's Protein Assay
1. Use 12*75 mm culture tubes and do samples, standards, and blanks in
triplicate.
2. Add 50 |^l of standards to appropriately labelled tubes.
3. Add 50 til of water to tubes labelled REAGENT BLANK.
4. Prepare a 20:1 dilution of homogenizing media (10 \i\ media + 190 ^l
water). Add 50 \x\ of dilute media to tubes labelled SAMPLE BLANK.
5. Prepare a 20:1 dilution of EACH tissue sample (10 \i\ sample + 190 jnl
water). Add 50 n-l of dilute sample to tubes labelled SAMPLE.
6. Add 0.5 ml of alkaline copper reagent to all tubes.
7. Mix well and let stand for 10 minutes at 25°C (room temperature).
8. Add 2.0 ml of phenol reagent to each tube. Mix each tube individually
IMMEDIATELY after adding phenol reagent.
9. Incubate for 5 minutes at 55°C.
10. Cool in tap water for 1 minute.
11. Read on spectrophotometer at 650 nm.
12. Plot standard curve to check linearity.

CALCULATION:

(A650 of sample - A65o of sample blank)
(A65o of standard - A65o of reagent blank)
Multiply by
Concentration of Standard (mg/ml) * 20 (dilution factor) = Protein concentration,
mg/ml
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Appendix E
Reagents
PBS, 0.015 M working solution (pH 7.6):

Na 2 HP0 4 * 7H20 (FW 268.1)
NaH 2 P0 4 * H20 (FW 138.0)
NaCI (FW 58.44)

1xPBS
3.495 g
0.27 g
9.0 g

10x PBS
34.95 g
2.7 g
90 g

For 1x PBS solution:
• Measure reagents, add approx. 950 ml dH 2 0, pH to 7.6, and bring up to 1
L with dH 2 0. Store at room temperature.
For 10x PBS solution (recommended):
• Measure reagents, add approx. 950 ml dH 2 0, pH to 7.6, and bring up to 1
L with dH 2 0. Store at room temperature. Each day: take out 100 ml of 10x
stock PBS solution and add 900 ml dH 2 0.
0.5% Triton X-100 solution:
• Add 5 ml of Triton X-100 to 995 ml of 1x PBS. Store at room temperature.
0.6% H7Q? solution (in MeOH):
• Add 10 ml of 30% stock H 2 0 2 to 490 ml absolute methanol. Store at 4°C.
Blocking solution (5% normal goat serum in 5% nonfat milk powder/PBS):
For 10 ml:
• Weigh out 0.5 g nonfat milk powder.
• Add 9.5 ml 1x PBS.
• Add 500 [i\ normal goat serum.
• Store at 4°C.
For 5 ml of a 1:20 dilution of Pax 7 antibody:
• Take 4.75 ml blocking solution and add 250 jal primary antibody
(monoclonal mouse anti-Pax-7 antibody, purchase from Developmental
Studies Hybridoma Bank)
For 5 ml of a 1:50 dilution of MvoD antibody:
• Take 4.9 ml blocking solution and add 100 JLLI primary antibody
(monoclonal mouse anti-MyoD1, clone 5.8A, Dako)
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DAKO LSAB-2 kit (HRP) for use on rat tissue, order catalogue #K0609
Website: http://www.dakocytomation.ca
Sodium acetate (anhydrous) (C2H302Na) (0.1 N)
• 0.82 g in 100 ml of H 2 0
pH 4.2

(mw 82.03)

Glycine Buffer (0.1 M)
pH 10.8
A) 0.375g glycine (C2H5NO2, mw 75.07) + 0.2922g NaCI (mw 58.44) in 50
mlH 2 0
B) 0.4 g of NaOH (mw 40) in 100 ml of H 2 0
•

Mix 52.2 ml of A and 47.8 ml of Band pHto 10.8

Substrate: p-nitrophenyl-beta-D-glucuronide (5mM) (sigma N-1627) (mw
315.2)
• 7.88 mg in 5 ml H 2 0
Standard: p-nitrophenol (mw 139.1)
15.65 mg p-nitrophenol/10 ml of H 2 0 gives [11.25mM]
Need 50|al of [11.25mM] p-nitrophenol in 2.25 ml of solution gives a total
[0.25mM]
Serial Dilution
0.25
Use above
0.125.1
1 ml 0.25 mM and 1 ml of H 2 0
0.0625
1 ml 0.125 mM and 1 ml of H 2 0
0.3125
1 ml 0.0625 mM and 1ml of H 2 0
0.156
1 ml 0.03125 mM and 1 ml of H 2 0
10 mM liquid p-NP solution was purchased from Sigma, and serial dilutions were
made to the following concentrations:
Standard, mM
0.125
0.0625
0.03125
0.015625
0 (distilled water)

Take
Take
Take
Take

To make:
563 nl of 10 mM p-NP stock and add 437 |al dH 2 0
500 JLII of 0.125 mM solution and add 500 [i\ dH 2 0
500 \x\ of 0.0625 mM solution and add 500 (al dH 2 0
500 |al of 0.03125 mM solution and add 500 |al dH 2 0
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